Abstract PR009: Role of treatment on racial and ethnic disparities in heart disease mortality among U.S. breast cancer survivors, 2000-2018
Jacqueline B. Vo(National Institutes of Health), Amy Berrington de González(Institute of Cancer Research), Ana Barac(Inova Fairfax Hospital), Katherine Ho, Jongeun Rhee(Uniformed Services University of the Health Sciences), Cody Ramin(Cedars-Sinai Medical Center), Wayne R. Lawrence(Albany State University), Lene H.S. Veiga(National Cancer Institute)
Cited by 0
Related Papers
Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents
|The Lancet|2016|2.8k
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
|European Heart Journal|2022|2.7k
Body-Mass Index and Mortality among 1.46 Million White Adults
|New England Journal of Medicine|2010|2.3k
Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2017|1.3k
Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies: A Position Statement and New Risk Assessment Tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in Collaboration with the International Cardio-Oncology Society
|European Journal of Heart Failure|2020|767